Owners, management and financials
CVR: 44423472
DKK -71,649
Gross profit
Net result: DKK 18,598,651
Thomas Engelbrecht Nordkild Jonassen (100%)
CVR · view owners
Thomas Engelbrecht Nordkild Jonassen
CVR · view management
Active
Founded 9 November 2023
CVR · view overview
0 employees
Annual report 2025 · average
Name registered: TJ Biotech Invest ApS
CVR · 09/11/2023
View the full event history
TJ Biotech Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -71,649 and a net result of DKK 18,598,651 compared with DKK -311,026 the year before. Equity in the 2025 report amounted to DKK 36,311,523.
Selskabets formål er at eje kapitalandele i helt eller delvist ejede datterselskaber, investering samt hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -72 t. | 18.6 mio. | 38.9 mio. | 36.3 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | -153 t. | -311 t. | 17.7 mio. | 17.7 mio. | - | |
| 202301/01/2023 – 31/12/2023 | -198 t. | -106.7 mio. | 18 mio. | 18 mio. | - |
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of TJ Biotech Invest ApS is 44423472.
TJ Biotech Invest ApS is owned by Thomas Engelbrecht Nordkild Jonassen.
The management of TJ Biotech Invest ApS consists of Thomas Engelbrecht Nordkild Jonassen.
In 2025, TJ Biotech Invest ApS reported a gross profit of DKK -71,649.
TJ Biotech Invest ApS had an average of 0 employees in the 2025 financial year according to the annual report.
TJ Biotech Invest ApS was founded on 9 November 2023.
Claim this page to add your logo and social links. Free to get started.
As of September 7, 2026, Cedra Godkendt Revisionsaktieselskab has been appointed auditor of TJ Biotech Invest ApS.
As of September 7, 2026, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of TJ Biotech Invest ApS.
TJ Biotech Invest ApS has published its annual report for 2025. Gross profit came to DKK -71,649, and the net result was DKK 18,598,651.
TJ Biotech Invest ApS has published its annual report for 2024. Gross profit came to DKK -153,453, and the net result was DKK -311,026.
TJ Biotech Invest ApS has published its annual report for 2023. Gross profit came to DKK -197,688, and the net result was DKK -106,684,190.
As of November 9, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of TJ Biotech Invest ApS.
As of November 9, 2023, Thomas Engelbrecht Nordkild Jonassen is registered as director of TJ Biotech Invest ApS.
As of November 9, 2023, Thomas Engelbrecht Nordkild Jonassen is registered as an owner of TJ Biotech Invest ApS with an ownership share of 100%.
TJ Biotech Invest ApS was founded on November 9, 2023.
Companies in the same industry and area
CVR 45770788
CVR 46818423
CVR 39998998
CVR 33879229
CVR 31091934
